Open AccessAbstract CT181: Phase I/II clinical trial results for 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) as treatment for adolescents and young adults (AYA) with cancers involving the CNS
Author(s) -
Lee Roy Morgan,
Roy S. Weiner,
Tahir Mahmood,
Marcus Ware,
Andrew H. Rodgers,
Manish Bhandari,
Philip Friedlander
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct181
Subject(s) - medicine , cmax , cancer , lung cancer , pharmacokinetics , adverse effect , phases of clinical research , clinical trial , gastroenterology , oncology